Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Associate Partners:

  • Kotak Mutual Fund
  • Pharmeasy
  • Indiabulls
  • SBI

Presenting Partner

Life Insurance Corporation of India

Moneycontrol

Budget 2022

Technology Partner

Dell Technologies

Associate Partners

Kotak Mutual Fund
Pharmeasy
Indiabulls
SBI
Register Now!“Unlock Credit” Pre-Budget discussion on “Solving the enterprise lending and borrowing puzzle in Budget 2022” 29th January at 3pm

Vivo Biotech Consolidated September 2021 Net Sales at Rs 10.17 crore, down 30.66% Y-o-Y

November 11, 2021 / 11:23 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Consolidated quarterly numbers for Vivo Biotech are:

Net Sales at Rs 10.17 crore in September 2021 down 30.66% from Rs. 14.67 crore in September 2020.

Quarterly Net Profit at Rs. 0.28 crore in September 2021 down 86.83% from Rs. 2.10 crore in September 2020.

EBITDA stands at Rs. 3.87 crore in September 2021 down 35.39% from Rs. 5.99 crore in September 2020.

Vivo Biotech EPS has decreased to Rs. 0.20 in September 2021 from Rs. 1.63 in September 2020.

Close

Vivo Biotech shares closed at 68.65 on November 10, 2021 (BSE) and has given 4.89% returns over the last 6 months and 71.63% over the last 12 months.

Vivo Biotech
Consolidated Quarterly Resultsin Rs. Cr.
Sep'21Jun'21Sep'20
Net Sales/Income from operations10.1713.0014.67
Other Operating Income------
Total Income From Operations10.1713.0014.67
EXPENDITURE
Consumption of Raw Materials------
Purchase of Traded Goods1.642.021.98
Increase/Decrease in Stocks-1.161.31-1.01
Power & Fuel------
Employees Cost2.032.192.58
Depreciation1.742.861.31
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses3.821.795.13
P/L Before Other Inc., Int., Excpt. Items & Tax2.102.834.68
Other Income0.030.22--
P/L Before Int., Excpt. Items & Tax2.133.054.68
Interest1.060.861.03
P/L Before Exceptional Items & Tax1.072.193.65
Exceptional Items------
P/L Before Tax1.072.193.65
Tax0.790.951.54
P/L After Tax from Ordinary Activities0.281.242.10
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period0.281.242.10
Minority Interest------
Share Of P/L Of Associates------
Net P/L After M.I & Associates0.281.242.10
Equity Share Capital14.2014.2012.89
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS0.200.871.63
Diluted EPS0.190.841.63
EPS After Extra Ordinary
Basic EPS0.200.871.63
Diluted EPS0.190.841.63
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

first published: Nov 11, 2021 11:11 am
Sections
ISO 27001 - BSI Assurance Mark